Fibrin gel architecture influences endogenous fibrinolysis and may promote coronary artery disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 11, 2006, Pages 2419-2420

  Silveira, Angela ^a   Hamsten, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRIN; FIBRINOGEN;

CONFOCAL MICROSCOPY; CORONARY ARTERY DISEASE; CROSS LINKING; EDITORIAL; ENVIRONMENTAL FACTOR; EX VIVO STUDY; FIBRIN CLOT; FIBRINOLYSIS; HEREDITY; HUMAN; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; VISCOELASTICITY;

BLOOD COAGULATION; BLOOD VISCOSITY; CORONARY ARTERIOSCLEROSIS; ELASTICITY; FIBRIN; FIBRINOLYSIS; GELS; HUMANS;

EID: 33750210373     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000245798.26855.88     Document Type: Editorial

References (16)

1. Fatah K, Hamsten A, Blombäck B, Blombäck M. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost. 1992;68:130-135.
2. Fatah K, Blombäck M, Tornvall P, Moor E, Silveira A, Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at young age. Thromb Haemost. 1996;76:535-540.
3. Nguyen G, Horellou MH, Kruithof EK, Conard J, Samama MM. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis. Blood. 1988;72:601-605.
4. Mosnier LO, von dem Borne PA, Meijers JC, Bouma BN. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb Haemost. 1998;80:829-835.
5. Carr ME Jr, Alving BM. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul Fibrinolysis. 1995;6:567-573.
6. Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000;20:1354-1361.
7. Collet JP, Allali Y, Lesty C, Tanguy ML, Silvain J, Ankri A, Blanchet B, Dumaine R, Gianetti J, Payot L, Weisel JW, Montalescot G. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol. 2006;26:2567-2573.
8. Blombäck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Åslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 1989;997:96-110.
9. Collet JP, Shuman H, Ledger RE, Lee S, Weisel JW. The elasticity of an individual fibrin fiber in a clot. Proc Natl Acad Sci U S A. 2005;102:9133-9137.
10. Weisel JW. The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem. 2004;112:267-276.
11. Janmey PA. A torsion pendulum for measurement of the viscoelasticity of biopolymers and its application to actin networks. J Biochem Biophys Methods. 1991;22:41-53.
12. Lorand L. Factor XIII and the clotting of fibrinogen: from basic research to medicine. J Thromb Haemost. 2005;3:1337-1348.
13. Collet JP, Moen JL, Veklich YI, Gorkun OV, Lord ST, Montalescot G, Weisel JW. The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood. 2005;106:3824-3830.
14. Scott EM, Ariens RA, Grant PJ. Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol. 2004;24:1558-1566.
15. Standeven KF, Ariens RAS, Grant PJ. The molecular physiology and pathology of fibrin structure/function. Blood Rev. 2005;19:275-288.
16. Collet JP, Nagaswami C, Farrell DH, Montalescot G, Weisel JW. Influence of γ' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler Thromb Vasc Biol. 2004;24:382-386.